Clinical Trials Logo

Clinical Trial Summary

Femoral nerve block using 0.25% bupivacaine or 0.5% bupivacaine provides a longer time for analgesia after Anterior Cruciate Ligament (ACL) reconstruction.


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms

  • Analgesia After ACL Reconstruction

NCT number NCT01593566
Study type Interventional
Source Mahidol University
Contact
Status Completed
Phase Phase 4
Start date April 2011
Completion date June 2013